Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors.

Saito Y, Berk BC.

J Mol Cell Cardiol. 2001 Jan;33(1):3-7. Review.

PMID:
11133218
2.
4.

Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.

Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL.

Can J Physiol Pharmacol. 2003 Feb;81(2):159-67.

PMID:
12710530
5.

GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation.

Delcourt N, Bockaert J, Marin P.

Trends Pharmacol Sci. 2007 Dec;28(12):602-7. Epub 2007 Nov 14. Review.

PMID:
18001849
6.

A novel function of angiotensin II in skin wound healing. Induction of fibroblast and keratinocyte migration by angiotensin II via heparin-binding epidermal growth factor (EGF)-like growth factor-mediated EGF receptor transactivation.

Yahata Y, Shirakata Y, Tokumaru S, Yang L, Dai X, Tohyama M, Tsuda T, Sayama K, Iwai M, Horiuchi M, Hashimoto K.

J Biol Chem. 2006 May 12;281(19):13209-16. Epub 2006 Mar 16.

7.
8.

Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways.

Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD, Baker KM.

J Mol Cell Cardiol. 1997 Nov;29(11):2893-902. Review.

PMID:
9405164
9.

Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase.

Eguchi S, Inagami T.

Regul Pept. 2000 Jul 28;91(1-3):13-20. Review.

PMID:
10967198
10.

Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature.

Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD, Eguchi S.

Curr Vasc Pharmacol. 2006 Jan;4(1):67-78. Review.

PMID:
16472178
11.

Angiotensin II regulates phosphoinositide 3 kinase/Akt cascade via a negative crosstalk between AT1 and AT2 receptors in skin fibroblasts of human hypertrophic scars.

Liu HW, Cheng B, Yu WL, Sun RX, Zeng D, Wang J, Liao YX, Fu XB.

Life Sci. 2006 Jun 27;79(5):475-83. Epub 2006 Mar 7.

PMID:
16522324
12.

Hybrid formation between the intracellular faces of the bradykinin B2 and angiotensin II AT1 receptors and signal transduction.

Yu J, Prado GN, Taylor L, Pal-Ghosh R, Polgar P.

Int Immunopharmacol. 2002 Dec;2(13-14):1807-22. Review.

PMID:
12489795
13.

Angiotensin II signaling pathways mediated by tyrosine kinases.

Yin G, Yan C, Berk BC.

Int J Biochem Cell Biol. 2003 Jun;35(6):780-3. Review.

PMID:
12676164
14.
15.

A novel phosphoinositide 3-kinase-dependent pathway for angiotensin II/AT-1 receptor-mediated induction of collagen synthesis in MES-13 mesangial cells.

Yano N, Suzuki D, Endoh M, Zhao TC, Padbury JF, Tseng YT.

J Biol Chem. 2007 Jun 29;282(26):18819-30. Epub 2007 May 10.

17.

Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.

Thomas SM, Bhola NE, Zhang Q, Contrucci SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC, Grandis JR.

Cancer Res. 2006 Dec 15;66(24):11831-9.

18.
19.

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

Mehta PK, Griendling KK.

Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97. Epub 2006 Jul 26. Review.

20.

EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors.

Voisin L, Foisy S, Giasson E, Lambert C, Moreau P, Meloche S.

Am J Physiol Cell Physiol. 2002 Aug;283(2):C446-55.

Supplemental Content

Support Center